These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9622843)

  • 1. [Unconventional transmissible agents: risk of transmission by blood].
    Dormont D
    Transfus Clin Biol; 1998 Apr; 5 Suppl 1():33S-35S. PubMed ID: 9622843
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety of human blood: experimental TSE/prion infectivity studies.
    Cervenakova L
    Transfus Clin Biol; 2001 Jun; 8(3):260. PubMed ID: 11499973
    [No Abstract]   [Full Text] [Related]  

  • 3. Prion disease and blood transfusion.
    Flanagan P; Barbara JA
    Transfus Med; 1996 Sep; 6(3):213-5. PubMed ID: 8885149
    [No Abstract]   [Full Text] [Related]  

  • 4. Transmissible spongiform encephalopathies.
    Sejvar JJ; Schonberger LB; Belay ED
    J Am Vet Med Assoc; 2008 Dec; 233(11):1705-12. PubMed ID: 19046027
    [No Abstract]   [Full Text] [Related]  

  • 5. Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives.
    Yap PL; Leaver HA; Gillon J
    Vox Sang; 1998; 74 Suppl 2():131-4. PubMed ID: 9704435
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines against transmissible spongiform encephalopathies: an urgent need?
    Bade S; Frey A
    Hum Vaccin; 2008; 4(1):79-81. PubMed ID: 18441531
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk of transmission of nvCJD by blood transfusion and the potential benefits of leucodepletion.
    Turner M
    Transfus Sci; 1998 Dec; 19(4):331-2. PubMed ID: 10351147
    [No Abstract]   [Full Text] [Related]  

  • 8. How to limit the spread of Creutzfeldt-Jakob disease.
    Dormont D
    Infect Control Hosp Epidemiol; 1996 Aug; 17(8):521-8. PubMed ID: 8875297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spongiform encephalopathies: a tale of cannibals, cattle, and prions.
    Mariani SM
    MedGenMed; 2003 Sep; 5(3):42. PubMed ID: 14600678
    [No Abstract]   [Full Text] [Related]  

  • 10. [The prion hypothesis and the human prion diseases].
    Aguzzi A
    Berl Munch Tierarztl Wochenschr; 2002; 115(3-4):91-8. PubMed ID: 11938572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant Creutzfeldt Jakob Disease.
    Painter MJ
    J Infect; 2000 Sep; 41(2):117-24. PubMed ID: 11023754
    [No Abstract]   [Full Text] [Related]  

  • 13. Removal of TSE agents from blood products.
    Foster PR
    Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
    [No Abstract]   [Full Text] [Related]  

  • 14. Transmissible spongiform encephalopathy agents and animal sera.
    Dormont D
    Dev Biol Stand; 1999; 99():25-34. PubMed ID: 10404872
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of prion diseases in a hospital setting. Protocol used at the Ospedale Bellaria di Bologna].
    Suzzi R; Ricci A; Corazza G; Bolini G; Benati L; Michelucci R; Riccioni L; Fabrizi A; Roncaroli F
    Pathologica; 1997 Aug; 89(4):449-53. PubMed ID: 9471616
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of the causal agents of Creutzfeldt-Jakob disease and other human prion diseases.
    Taylor D
    Brain Pathol; 1996 Apr; 6(2):197-8. PubMed ID: 8737933
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in screening test development for transmissible spongiform encephalopathies.
    Cervenakova L; Brown P
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):873-80. PubMed ID: 15566331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Much news on the prion front].
    Norrby E
    Lakartidningen; 2010 May 5-11; 107(18):1218-24. PubMed ID: 20521593
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical management of prion disease].
    Itoyama Y
    No To Shinkei; 1997 Aug; 49(8):707-11. PubMed ID: 9282364
    [No Abstract]   [Full Text] [Related]  

  • 20. Prion disease: the shape of things to come.
    Khamsi R
    Nature; 2006 Jan; 439(7073):134-5. PubMed ID: 16407924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.